---
title: "中国药品监管机构将恒瑞医药的 SHR-1918 注射液纳入优先审评程序"
description: "中国药品监管局将恒瑞医药的 SHR-1918 注射剂列入优先审评"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/276838200.md"
published_at: "2026-02-25T05:42:03.000Z"
---

# 中国药品监管机构将恒瑞医药的 SHR-1918 注射液纳入优先审评程序

> 中国药品监管局将恒瑞医药的 SHR-1918 注射剂列入优先审评

### Related Stocks

- [600276.CN - 恒瑞医药](https://longbridge.com/zh-CN/quote/600276.CN.md)
- [513060.CN - 博时恒生医疗保健(QDII-ETF)](https://longbridge.com/zh-CN/quote/513060.CN.md)
- [520690.CN - 博时恒生港股通创新药精选ETF](https://longbridge.com/zh-CN/quote/520690.CN.md)
- [01276.HK - 恒瑞医药](https://longbridge.com/zh-CN/quote/01276.HK.md)
- [516820.CN - 平安中证医疗创新ETF](https://longbridge.com/zh-CN/quote/516820.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Hengrui Pharma Gets Nod for Solid Tumor Injection's Clinical Trials | Hengrui Pharma Gets Nod for Solid Tumor Injection's Clinical Trials | [Link](https://longbridge.com/zh-CN/news/273791098.md) |
| Palumbo Wealth Management LLC Buys New Stake in ProShares Ultra Nasdaq Biotechnology $BIB | Palumbo Wealth Management LLC acquired a new stake in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) during the third | [Link](https://longbridge.com/zh-CN/news/276735169.md) |
| Understanding the Limits of Cosmetic Injectables and When to Opt for a Facelift with Dr. Nicole Schrader | Dr. Nicole Schrader discusses the limitations of cosmetic injectables for facial rejuvenation and when to consider a fac | [Link](https://longbridge.com/zh-CN/news/276776925.md) |
| China Medical System Gets China Acceptance for Atopic Dermatitis Drug | China Medical System Gets China Acceptance for Atopic Dermatitis Drug | [Link](https://longbridge.com/zh-CN/news/276718382.md) |
| Shanghai Fosun Pharmaceutical Units Trial Nod for Lung Cancer Drug in China | Shanghai Fosun Pharmaceutical Units Trial Nod for Lung Cancer Drug in China | [Link](https://longbridge.com/zh-CN/news/276886600.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。